Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
ZacksThe placebo-controlled, phase IIb study will investigate the efficacy and safety of Nektar’s (NKTR) rezpeg in patients with severe to very severe alopecia areata.
The placebo-controlled, phase IIb study will investigate the efficacy and safety of Nektar’s (NKTR) rezpeg in patients with severe to very severe alopecia areata.